S&P Futures
3,994.75 +24.25 (+0.61%) Dow Futures
32,381.00 +123.00 (+0.38%) Nasdaq Futures
12,833.00 +126.00 (+0.99%) Russell 2000 Futures
1,759.10 +18.10 (+1.04%) Crude Oil
70.59 -0.31 (-0.44%) Gold
1,979.70 +30.10 (+1.54%)
Treatment.Com International Inc. (TREIF)
- GlobeNewswire
Treatment’s Debut AI-driven Health App Getting Five Star Reviews from Doctors
VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), is a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. Treatment’s landmark debut product, the Treatment Digital Health App, has been garnering five-star reviews on both the Apple App Store and the Google Play Store. Users’ comments
- GlobeNewswire
Treatment Announces Convertible Debenture Private Placement
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions, announces the proceeding of a non-brokered private placement, raising aggregate gross proceeds of up to $1,250,000 in unsecured convertible debentures (the “Private Placement”). Each
